Please Wait...

Margaret Ziola

Translation skills

Main profile

Margaret Ziola, MD
Medical Director, Cardiology and Neurovascular

In her position as Medical Director, Cardiology and Neurovascular at Synarc, she is responsible for the scientific oversight of all cardiovascular projects including coordination and collaboration with key opinion leaders and expert readers as well as our Sponsor's scientific counterparts. Dr. Ziola participates in clinical trial protocol design and data interpretation and regulatory strategy planning. She oversees the quality of Synarc's cardiology and neurovascular reading services and explores new applications of imaging to clinical trial research.

Dr. Ziola has more than twenty years of cardiovascular experience in support of pharmaceutical research and development programs. Her expertise includes clinical analysis, interpretation, and reporting of cardiac safety data for over 100 clinical trials in various therapeutic indications, including cardiovascular, infectious disease, oncology, CNS, gastroenterology, and endocrinology.

Dr. Ziola holds her medical degree from the Nicolaus Copernicus Jagiellonian University Medical School in Krakow, Poland. She has participated in expert meetings, given invited lectures and co-authored several scientific articles.

Prior to joining Synarc, Dr. Ziola worked at ARYx Therapeutics leading global cardiovascular clinical trials design, conduct and monitoring. Earlier in her career, she served as Director of Cardiovascular Clinical Services position at Gentiae Clinical Research, a cardiovascular core lab she helped establish, supporting central reading of cardiac imaging and electrocardiography. Prior to that she was affiliated with the groundbreaking Ischemia Research and Education Foundation.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Sponsor insights on site and patient payments: https://t.co/VNiwaeDNWi
Bioclinica (3 hours ago)
ICYMI: Catch up on FDA Draft Guidance on BP Response in clinical trials https://t.co/uJp90qqQJx https://t.co/2dNI4AvXYU
Bioclinica (Yesterday)
RT @Xtalks: Detection and Monitoring in #FattyLiver #ClinicalTrials: The Role of Medical Imaging NASH is characterized by the presence of a…
Bioclinica (Yesterday)
RT @FCR_News_Today: CROs Deliver Shorter Cycle Times, Says New Tufts Report. #ClinicalTrial #ClinicalResearch https://t.co/PWe7qIGewt @…
Bioclinica (4 days ago)
RT @EMA_News: Today we are saying ‘hallo’ to our new home. Thank you, #Amsterdam and the Netherlands, for the warm welcome! https://t.co/hi…
Bioclinica (4 days ago)
RT @ACROhealth: How are patients finding #clinicaltrials? @Microsoft thinks chat bots could be the next recruitment frontier: #medtech #cli…
Bioclinica (4 days ago)

Latest Blogs:

Site Payments Solutions
Nonalcoholic steatohepatitis (NASH) development programs
Dr. Joby John
Transformational Trends in Investigator Site Payments
Clinical Supply Chain Success: Leveraging Technology
Blood pressure monitor
Prescription box